Cytek Biosciences
CTKB
CTKB
124 hedge funds and large institutions have $541M invested in Cytek Biosciences in 2024 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 41 increasing their positions, 37 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
26% less capital invested
Capital invested by funds: $728M → $541M (-$187M)
57% less call options, than puts
Call options by funds: $89K | Put options by funds: $209K
Holders
124
Holding in Top 10
–
Calls
$89K
Puts
$209K
Top Buyers
| 1 | +$3.27M | |
| 2 | +$3.25M | |
| 3 | +$2.09M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$1.64M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$819K |
Top Sellers
| 1 | -$5.56M | |
| 2 | -$2.37M | |
| 3 | -$1.03M | |
| 4 |
Barclays
London,
United Kingdom
|
-$555K |
| 5 |
JP Morgan Chase
New York
|
-$417K |